What's new

Human medicines European public assessment report (EPAR): Emadine, emedastine, Date of authorisation: 27/01/1999, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Emadine, emedastine, Date of authorisation: 27/01/1999, Revision: 27, Status: Authorised

Mar 21, 2025 - 14:30
 0
Human medicines European public assessment report (EPAR): Emadine, emedastine, Date of authorisation: 27/01/1999, Revision: 27, Status: Authorised
Human medicines European public assessment report (EPAR): Emadine, emedastine, Date of authorisation: 27/01/1999, Revision: 27, Status: Authorised
Read More

Tags:

Previous Article

STAT+: Pharmalittle: We’re reading about J&J building U.S. plants, a weight loss...

Next Article

Shareholder Engagement on Compensation Matters: Special Time-Sensitive Complicat...

Related Posts

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - June 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 17 June 2025, 11:00 (CEST) to 17 June 2025, 12:00 (CEST)

Questions and answers clinic on Product Management Serv...

Mar 7, 2025  0

Human medicines European public assessment report (EPAR): Orserdu, elacestrant, Date of authorisation: 15/09/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Rinvoq, Upadacitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Immune system disorders, PIP number: P/0010/2024

Opinion/decision on a Paediatric investigation plan (PI...

Mar 13, 2025  0